Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary-Reference-Cited by-同舟云学术

Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary

Published:2021-11 Issue: Volume: Page:
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Johansson I.,Tempel D.,Dwarkasing J.T.,Rentroia-Pacheco B.,Mattsson J.,Ny L.,Olofsson Bagge R.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference21 articles.

1. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014;Aitken;Int J Cancer,2018

2. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men;Lyth;Br J Dermatol,2015

3. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Gershenwald;CA A Cancer J Clin,2017

4. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American society of clinical oncology and society of surgical oncology clinical practice guideline update;Wong;Ann Surg Oncol,2018

5. The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival;Baehner;Ann Surg Oncol,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAUSSS biomarker improves melanoma survival risk assessment;Journal of the European Academy of Dermatology and Venereology;2024-08-31

2. Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies;Journal of the American Academy of Dermatology;2024-05

3. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy;European Journal of Cancer;2024-05

4. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status;JAMA Surgery;2024-03-01

5. Validation of the Melanoma Institute of Australia’s Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma;Annals of Surgical Oncology;2024-01-12